Full View

Enhancement of carboplatin-and quercetin-induced cell death by roscovitine is Akt dependent and p53 independent in hepatoma cells

A Sharma, MK Bhat - Integrative Cancer Therapies, 2011 - journals.sagepub.com
Purpose. Hepatocellular carcinoma (HCC) is a common malignancy worldwide and has an
annual occurrence of one million new cases. Novel therapeutic strategies of increased …
被引用次数：17 相关文章

Enhancement of carboplatin-and quercetin-induced cell death by roscovitine is Akt dependent and p53 independent in hepatoma cells

A Sharma, MK Bhat - Integrative cancer therapies, 2011 - pubmed.ncbi.nlm.nih.gov
Purpose Hepatocellular carcinoma (HCC) is a common malignancy worldwide and has an
annual occurrence of one million new cases. Novel therapeutic strategies of increased …

Enhancement of Carboplatin-and Quercetin-Induced Cell Death by Roscovitine Is Akt Dependent and p53 Independent in Hepatoma Cells.

A Sharma, MK Bhat - Integrative Cancer Therapies, 2011 - search.ebscohost.com
Purpose. Hepatocellular carcinoma (HCC) is a common malignancy worldwide and has an
annual occurrence of one million new cases. Novel therapeutic strategies of increased …

Enhancement of Carboplatin-and Quercetin-Induced Cell Death by Roscovitine Is Akt Dependent and p53 Independent in Hepatoma Cells

A Sharma, MK Bhat - Integrative Cancer Therapies, 2011 - cir.nii.ac.jp
抄録< jats: p> Purpose. Hepatocellular carcinoma (HCC) is a common malignancy
worldwide and has an annual occurrence of one million new cases. Novel therapeutic …

Enhancement of carboplatin-and quercetin-induced cell death by roscovitine is Akt dependent and p53 independent in hepatoma cells.

A Sharma, MK Bhat - Integrative Cancer Therapies, 2011 - europepmc.org
Purpose Hepatocellular carcinoma (HCC) is a common malignancy worldwide and has an
annual occurrence of one million new cases. Novel therapeutic strategies of increased …